During the past decade, Ochsner LSU Health Saint Mary's Medical Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ochsner LSU Health Saint Mary's Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 4 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored, "SWOG Cancer Research Network" with 1 trials sponsored and "Wake Forest University Health Sciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ochsner LSU Health Saint Mary's Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Canadian Cancer Trials Group (CCTG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "University of Alabama at Birmingham" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Ochsner LSU Health Saint Mary's Medical Center" are "Metastatic Malignant Solid Neoplasm" (2 trials), "ALK Gene Rearrangement" (1 trials), "ALK Gene Translocation" (1 trials), "ALK Positive" (1 trials) and "Anatomic Stage IV Breast Cancer AJCC v8" (1 trials). Many other conditions were trialed in "Ochsner LSU Health Saint Mary's Medical Center" in a lesser frequency.

Most popular intervention types in "Ochsner LSU Health Saint Mary's Medical Center" are "Other" (9 trials), "Drug" (8 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (5 trials), "Questionnaire Administration" (4 trials), "Biospecimen Collection" (3 trials), "Carboplatin" (2 trials) and "Clinical Observation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ochsner LSU Health Saint Mary's Medical Center" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ochsner LSU Health Saint Mary's Medical Center". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ochsner LSU Health Saint Mary's Medical Center, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ochsner LSU Health Saint Mary's Medical Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".